Industry Insight
Across antibody discovery and structural biology, R&D teams increasingly need a single computational stack that can handle antibody–antigen, protein–ligand, and protein–nucleic acid systems while feeding predictions into downstream validation. In practice, however, several bottlenecks remain widespread: multi-molecule modeling workflows are often fragmented across separate tools; many models still operate as black boxes with limited reproducibility or extensibility; experimental restraints are not always incorporated in a researcher-friendly way; and complex assembly modeling can be expensive in both compute and engineering effort, making large-scale iteration difficult.
As a result, demand is rising for structure prediction platforms that are unified, open, reproducible, and compatible with real experimental workflows. The integration of Protenix into the AbSeekTM intelligent computing platform directly addresses these needs by bringing a more transparent, scalable, and research-ready approach to multi-molecule structure prediction for antibody R&D and structural biology.
Introduction
The AbSeekTM intelligent computing platform now deploys Protenix, a fully open-source foundation model for multi-molecule structure prediction developed by the ByteDance AML AI4Science team. As an open reproduction of AlphaFold3, Protenix can accurately predict the three-dimensional structures of complex systems within a unified architecture, including protein–protein, protein–ligand, and protein–nucleic acid assemblies, enabling full-scenario modeling from monomers to complexes.
Its deployment not only improves computational efficiency and modeling accuracy for tasks such as antibody–antigen modeling and binding prediction, but also strengthens reproducibility, interpretability, and extensibility for scientific users. For teams aiming to shorten the path from sequence to structure and from prediction to validation, this integration marks a meaningful step toward a more open era of AI-driven structure prediction on AbSeekTM.
Figure 1. Protenix tool page on the AbSeekTM platform
What Is Protenix?
Protenix is a multi-modal structure prediction model that supports end-to-end modeling of proteins, nucleic acids, and small molecules within a unified framework. Built on the methodological foundation of AlphaFold3, it opens up multi-molecule collaborative prediction to the research community through fully open-source training, inference, and data pipelines.
According to its official technical report, Protenix delivers strong overall performance:
- More than 80% success rate for protein–ligand docking at RMSD ≤ 2 Å;
- Average protein–protein complex prediction success rate above 70% at DockQ > 0.23;
- Up to 35.5% success rate for antibody–antigen systems at DockQ > 0.23.
For antibody R&D, Protenix is valuable not simply because it is another structure prediction model, but because it brings high-quality, multi-system, reproducible prediction into an open scientific setting where researchers can directly inspect the model, validate outputs, and adapt workflows to their own programs.
Figure 2. Performance of the Protenix model
What Changes Does Protenix Bring to the AbSeekTM Platform?
The deployment of Protenix represents a system-level upgrade for the platform, strengthening multi-molecule modeling from the underlying architecture to the end-user experience and creating a closer connection between exploratory research and industrial development.
1. From Monomers to Complexes: One Input, Multiple Modeling Scenarios
Traditional models often focus on a single task, such as monomer folding or a narrow class of complexes. By contrast, Protenix supports multimodal inputs and can model a broad range of systems within one framework, including protein–protein complexes, protein–ligand complexes, protein–DNA/RNA assemblies, and systems containing modified residues, metal ions, or cofactors.
This allows users to upload sequences or structures once and obtain models for multiple use cases more efficiently. For projects that need to expand into dedicated protein–protein docking analysis, the platform also provides a smoother bridge to downstream structure-based investigation.
Figure 3. Visualization module
2. High-Performance Computing Optimization: Faster, More Stable, More Cost-Efficient
On the inference side, Protenix integrates BF16 mixed-precision computation and customized CUDA kernel acceleration. Compared with traditional AlphaFold2 multi-chain workflows, it can deliver substantial efficiency gains under similar compute budgets, including 30–50% faster training, inference times within 10 minutes, and markedly lower memory usage. These engineering improvements are especially important for teams that need to evaluate large numbers of candidates or iterate rapidly on complex assemblies.
3. Better Integration with Experimental Data: Closer to Real Structures
Protenix supports the incorporation of experimental restraints during inference, such as distance restraints, known epitopes, or ligand-binding sites. When partial experimental information is provided, the model can adjust its structural sampling distribution accordingly, leading to predictions that are closer to biologically relevant conformations. Reported results indicate that adding one set of restraints can improve DockQ success by around 20%, while incorporating four sets of restraints can more than double prediction accuracy.
Within AbSeekTM, users can input these restraints through a form-based interface rather than manually constructing complex input files. Combined with the platform’s existing workflow design, this makes experimentally informed prediction more practical for real-world research programs.
Figure 4. Success rate of Protenix complex prediction with constraints
Who Should Use Protenix?
1. Biopharmaceutical Companies
- Accelerate candidate prioritization and structural validation through more automated modeling from sequence to complex;
- Support affinity analysis and mutation assessment using model confidence metrics and structural comparison;
- Improve project transparency by integrating predicted structures more naturally into internal R&D pipelines.
2. Academic Institutes and Research Laboratories
- Lower the barrier to modeling with a graphical interface rather than complex command-line deployment;
- Enable tighter experiment–computation integration by allowing users to input restraints directly into the prediction process;
- Expand the range of research objects, including non-canonical sequences, synthetic peptides, chimeric antibodies, and nucleic-acid-containing complexes.
3. AI for Science Researchers
- Access reproducible model architecture and data pipelines for method development and benchmarking;
- Support retraining and transfer learning for task-specific adaptation;
- Contribute to a broader open-source ecosystem for multimodal biomolecular modeling.
From Model to Ecosystem: Building a New Foundation for Intelligent Molecular Structure Research
The deployment of Protenix moves AbSeekTM closer to a complete path from sequence to structure and from prediction to experiment. It broadens the platform’s multi-molecule prediction capabilities while also improving usability in open science, structural interpretation, and collaborative R&D.
For antibody teams, the practical value is clear: high-quality structure prediction can be incorporated earlier into decision-making, experimental evidence can be fed back into modeling more naturally, and users can connect antibody structure prediction with the platform’s interaction analysis tool to build a more complete structure research path.
Looking ahead, continued improvements in antibody–antigen complex prediction, restraint-aware modeling, and open collaboration around multimodal models could make Protenix even more valuable for teams seeking reliable, interpretable, and actionable structural insights in real R&D settings.
Try it now: Choose Protenix on AbSeekTM and upload your sequence or complex file to begin multi-molecule structure prediction.
Open collaboration: We welcome academic groups, research institutions, and industry partners to explore innovative applications of Protenix in antibody drug discovery, structural biology, and multimodal molecular modeling.